Michael S. Businelle, PhD, is a Peggy and Charles Stephenson Endowed Chair in Cancer, Co-Director of the TSET Health Promotion Research Center, and Professor (tenured) in the Department of Family and Preventive Medicine at OUHSC. He is also the founding director of the NCI-designated Stephenson Cancer Center mHealth Shared Resource.
Over the past nine years, Businelle's team has developed the Insight mHealth platform, which enables researchers to rapidly create mobile applications that can use EMA and sensor data to identify environmental, cognitive, affective, physiological, and behavioral antecedents of health risk behaviors (e.g., smoking, heavy alcohol use, poor diet / inactivity / obesity, etc.) and deliver context-specific just-in-time adaptive interventions (JITAI) in real-time. To date, Insight has supported over 109 studies (60 with NIH funding) in five languages.
Businelle is currently PI/MPI on 6 ongoing NIH-funded studies including mHealth applications that focus on smoking cessation (R01MD019957; U54MD015946 Study 1, U54MD015946 Supplement, R34CA286803), alcohol cessation/reduction (R01AA030276), and anxiety/depression (R01MH126586). His primary goal is to improve understanding of the causes of health disparities and to create and disseminate effective smartphone based just-in-time adaptive interventions (JITAIs) that reduce health disparities.
Education:
Degree-Granting Institutions
Louisiana State University, Baton Rouge, LA, PhD, 2007, Clinical Psychology
Postgraduate Training
Postdoctoral Fellowship, Cancer Prevention Research, University of Texas MD Anderson Cancer Center, Houston, TX, 2007-2009
Clinical Psychology Resident, G.V. (Sonny) Montgomery Veterans Affairs Medical Center and the University of Mississippi Medical Center, Jackson, MS, 2006-2007
Funding:
Principal Investigator
1. R01MD019957 (MPIs: Businelle, Garey)
09/23/2024-06/30/2029
National Test of a Culturally Tailored mHealth Integrated Smoking Cessation and Mental Health Intervention for Black Adults with HIV
This study will test an innovative smoking cesation application for Black adults with HIV.
Total costs: $4,751,918
2. R34CA286803 (MPIs: Businelle, Garey, Sayette)
09/11/2024-08/31/2027
NIH/NCI
An Innovative Digitally-Delivered Olfactory Method for Reducing Cigarette Cravings and Supporting Smoking Cessation
This study will test a first of its kind ofactory delivery device that aims to reduce nicotine cravings in adults attempting to quit smoking.
Total costs: $900,000
3. R01AA030276 (PIs: Businelle, Oliver, & Walters)
08/20/2024-04/30/2029
NIH/NIAAA
Efficacy of a Smartphone-Based Just-In-Time Adaptive Intervention to Reduce Drinking Among Adults Experiencing Homelessness
This study will provide a rigorous efficacy test of the Smart-T alcohol app which is specifically designed to reduce drinking in adults experiencing homelessness.
Total costs: $3,264,979
4. R01MH126586 (MPIs: Businelle & Zvolensky)
05/01/2021–03/31/2025
NIH/NIMH
NCE start 05/01/2024
Mobile Health to Monitor Risk for COVID-19 and Improve Mental Health during the Pandemic
Evaluate the efficacy of the Easing Anxiety Sensitivity for Everyone (EASE) app (N=800) which includes COVID-19 symptom monitoring and intervention and targets anxiety sensitivity, a transdiagnostic individual difference factor implicated in the etiology, maintenance, and progression of anxiety and depressive symptoms.
Total costs: $2,679,216
5. R01CA221819 (PI: Businelle)
02/01/2019-01/31/2025
NIH/NCI (Clinical Trials#: NCT03740490)
NCE start 02/01/2024
Smartphone Based Smoking Cessation Intervention for Socioeconomically Disadvantaged Adults
This study (N=454) will compare the longer-term effects of the Smart-T smoking cessation app with the free and publically available NCI QuitGuide smoking cessation app (Aim 1). The second aim will determine if Smart-T messages that are tailored to address key smoking lapse risk variables in real-time (i.e., urge, stress, cigarette availability, cessation motivation) reduce participant ratings of these lapse risk variables compared with similar situations that do not receive this tailored content (QuitGuide group).
Direct & Indirect: $2,804,785 (Direct: $1,957,142)
6. TSET STCST00400_FY24 (PIs: Businelle & Kendzor)
07/01/2023–06/30/2026
Health Promotion Research Center
Total Costs: $15,150,000 (Direct: $13,772,727)
This grant funds the Health Promotion Research Center that Drs. Businelle and Kendzor co-direct.
7. U54MD015946 (PI: Obasi; Project MPIs: Businelle & Zvolensky)
09/01/2020–04/30/2025
NIH/NIMHD (Clinical Trials#: NCT04838236)
Overall grant title: HEALTH Center for Addictions Research and Cancer Prevention
Core Project title: Improving access to cigarette cessation treatment among African American smokers: Development and evaluation of an integrated mHealth application
We will refine and evaluate an initially developed and tested, novel, mobile intervention that targets sensitivity to bodily sensations among African American smokers and bridges the gap in access to care which has plagued this health disparities population.
Total costs: $11,848,265 (Direct: $8,031,234) OUHSC subaward (Total: $777,752; Direct: $536,380)
8. U54MD015946 Supp (PI: Obasi; Project MPIs: Businelle & Garey)
05/01/2022–04/30/2025
NIH/NIMHD
A Fully Automated and Culturally-Adapted mHealth Intervention for Smoking Cessation Among Black Smokers with HIV
We will adapt our already developed and preliminarily tested, culturally adapted, mHealth smoking cessation intervention for Black smokers (MASP) to incorporate HIV disease management skills that are uniquely applicable to Black adults with HIV (MASP+).
Total costs: $1,271,869 (direct costs: $1,051,967; OUHSC total costs $440,812)
9. OUHSC Pilot Funds (PIs: Businelle & Alexander; NCT04887558)
08/01/2021–07/31/2025
Smart-T Mental Health
This pilot randomized controlled trial will evaluate the feasibility of an innovative, evidence-based smoking cessation app tailored for smokers with serious mental illness (SMI). Seventy-five smokers with SMI will be randomly assigned to receive either (1) the NCI QuitGuide app, (2) a smoking cessation app that tracks and automatically intervenes upon psychological distress during a quit attempt and delivers real-time intervention messages tailored to the current level of lapse risk and current lapse triggers (Smart-T Mental Health; STMH), or (3) the STMH app with additional messaging focused on increasing adherence to nicotine replacement medications (STMH+).
10. TSET Pilot Funds (PI: Businelle)
05/15/2022-12/30/2025
OKquit – Testing a Novel Smartphone Application for Smoking Cessation with the Oklahoma Helpline
This study (N=500) is a randomized controlled trial that will evaluate the feasibility and initial efficacy of an innovative, evidence-based smoking cessation app tailored for smokers that contact the OTH for services.
Direct costs: $300,531
Co-Investigator
11. U01CA294811 (MPIs: Bui, Vidrine, & Xangsayarath)
08/12/2024–07/31/2029
NIH/NCI
Implementing Sustainable mobile health Technology to Optimize smoking cessation Program for Lao people with HIV (I-STOP)
The purpose of this study is to compare 2 smoking cessation implementation strategies in 8 antiretroviral therapy (ART) clinics in the 5 most populous provinces/regions across Laos, using a hybrid type-2 pragmatic effectiveness-implementation study and a parallel cluster randomized trial design. Specifically, we will compare an Ask-Advice-Connect (AAC) approach paired with our previously developed mHealth automated tobacco treatment program to an AAC approach paired with less resource intensive printed self-help material.
Total: $3,187,275 (Direct: $2,720,795)
12. R01NR020997 (PI: Santa Maria)
09/21/2023-08/31/2027
NIH/NINR
Examining the Efficacy of MY-RIDE, a mHealth Intervention to Reduce HIV in Youth Experiencing Homelessness
Building on the promising results of a pilot study with this population, we aim to fully test the efficacy of MY-RIDE on substance use and HIV prevention strategies. This mHealth approach sends timely, personalized HIV prevention messages at the time of heightened risk for engaging in HIV transmission behaviors.
OUHSC direct costs: $165,020 (total OUHSC costs: $239,280)
13. R01DA059471 (MPIs: Cropsey & Gamble)
09/18/2023-08/31/2027
NIH/NIDA
Medications for Opioid Use Disorder differentially modulate intrinsically photosensitive retinal ganglion cell function, sleep, and circadian rhythms: Implications for treatment
This project will investigate a special set of photosensitive neurons in the retina as an underlying mechanism for circadian rhythm and sleep disturbance from opioid use and medications for OUD that could lead to novel interventions and improve treatment outcomes.
OUHSC direct costs: $126,048 (total costs: $182,769)
14. U01CA261598 (PIs: Bui & Vidrine)
09/17/2021-08/31/2026
NIH/NCI
Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT)
Participants (n=800) will be randomized to one of 2 treatment groups: Standard Care (SC; n=400), or Automated Messaging (AM; n=400). SC consists of brief advice to quit smoking delivered by research staff, self-help written materials, and an 8-week supply of nicotine replacement therapy (NRT) in the form of transdermal patches. The primary outcome is biochemically confirmed self-reported 7-day point prevalence abstinence at 12-months post-study enrollment.
Total cost: $3,541,404
15. R01CA251451 (PI: Kendzor)
04/01/2021 – 03/31/2026
NIH/NCI
Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults
The purpose of this study is to evaluate the efficacy and cost-effectiveness of an automated, smartphone-based approach to incentivizing smoking cessation.
Total cost: $3,072,461
16. R21CA253600/R33CA253600 (PI: Bui)
07/01/2020-06/30/2025
NIH/NCI
Mobile Health Technology for Personalized Tobacco Cessation Support in Laos
The purpose of the study is to advance mHealth applications in tobacco-cessation treatment in low- and middle-income settings and subsequently reduce tobacco-related morbidities and mortality.
Total costs: $1,121,268 (Direct costs: $931,460)
17. R21CA253600-S1 (PI: Bui)
09/01/2021–08/31/2024
NIH/NCI Administrative Supplement
Mobile Health Technology for Personalized Tobacco Cessation Support among Cancer Survivors in Laos (SurvLaos)
This pilot RCT aims to adapt and evaluate the efficacy of our theoretically and empirically based mobile health technology to help cancer survivors and their caregivers quit smoking tobacco in Lao People’s Democratic Republic.
Total costs:: $99,846 (Direct costs: $76,293)
18. R01 DA046096-01 (PI: Cropsey)
07/15/2020-04/30/2025
NIH/NIDA
Circadian and sleep mechanisms among racial groups for nicotine dependence, craving, and withdrawal
The overall goal for this project is to examine how sleep and nicotine dependence are related across racial ethnic groups.
Total Costs: $2,779,141 (Direct: $1,938,617) OUHSC Subaward (Total: $201,193; Direct: $138,755)
19. R01CA231952 (PIs: D. Vidrine & J. Vidrine)
04/01/2019–11/30/2024
NIH/NCI
Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers
The overall goal of this project is to collaborate with a large food bank to evaluate the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention.
Total Costs: $2,890,621 (Direct: $1,833,532) OUHSC subaward (Total: $152,466; Direct $105,150)
20. P30 CA225520 (PI: Mannel; Businelle: Dir mHeath Shared Resource)
05/01/2018–04/30/2028
NIH/NCI
Stephenson Cancer Center – Cancer Center Support Grant
Dr. Businelle is the Scientific Director of the NCI designated
Stephenson Cancer Center mHealth Shared Resource. The shared resource enables researchers to rapidly create mobile applications that identify environmental, cognitive, affective, physiological and behavioral antecedents of cancer risk behaviors (e.g., smoking, heavy alcohol use, poor diet, inactivity, obesity, etc.) and deliver context-specific adaptive interventions in real time.
Total Costs: $20,338,846 (Direct: $14,073,242)
Consultant
21. R01CA282223 (PI: Hoeppner)
08/03/2023-07/31/2028
NIH/NCI
Randomized clinical trial to test the efficacy of a smartphone app for smoking cessation for nondaily smokers
This study will test the effectiveness of the Smiling instead of Smoking (SiS) app in a sample of nondaily smokers. Dr. Businelle will serve as a consultant on this innovative project.
22. R01DA053171 (PI: Santos)
09/01/2021–08/31/2024
NIH/NIDA
Methamphetamine-using MSM
This is a double-blind, phase 2b, placebo-controlled trial in which 54 meth-using MSM will be randomly assigned (2:1) to receive 12 weeks of as-needed oral naltrexone enhanced with an EMA-informed EMI platform, or as-needed placebo with EMI to evaluate treatment effects on methamphetamine use and sexual risk behaviors.
23. U54MD015946A Pilot Award (MPIs: Garey & Fernandez)
08/09/2024-07/31/2026
NIH/NIMHD
Freedom to Reach Emotional Empowerment: An mHealth App for Black Women with HIV
This study will test a novel, culturally sensitive mHealth app that aims to improve the health of Black women with HIV by increasing access to mental health treatment and offering support and encouragement for maintaining HIV care.
Mentor
24. K99/R00 DA054255 (PI: Ra)
07/01/2024–06/20/2029
NIH/NIDA
Title: Using Mobile Technology to Examine Mechanisms Linking Sleep and Smoking Cessation
Direct Costs (initial year): $98,745
Role: Mentor
25. K23AA030804 (PI: Redmond)
09/20/2023-08/31/2028
Latinx Hazardous Drinkers: Evaluating Microaggressions
This work will provide a nuanced approach to examining minority stress and hazardous drinking among Latinx individuals and poses a highly unique training opportunity.
Total costs: $937,710 (Direct costs: $868,250)
Role: Co-mentor
26. K08CA266937 (PI: Azizoddin)
07/01/2022–06/30/2027
NIH/NCI (NCI)
Integrating pain-CBT into an mHealth analgesic support intervention for patients with chronic pain from advanced cancers
This study seeks to improve cancer patients’ pain self-management by adapting and integrating cognitive behavioral therapy for pain into an existing mHealth intervention designed to optimize pharmacologic management (e.g., daily pain/opioid monitoring and tailored advice) for patients with advanced cancer.
Total costs: $958,425 (Direct costs: $$887,753)
Role: Mentor
27. K01MD015295 (PI: Alexander)
05/08/2021–1/31/2026
NIH/NIMHD
HealthyCells: A Culturally-Tailored Smoking Cessation Smartphone Intervention for African Americans with Adjunctive Treatment for Sedentary Behavior
This NIMHD career development award focuses on developing an innovative culturally tailored smartphone intervention that uses contingency management and sedentary behavior reduction to improve smoking cessation outcomes among African American smokers.
Total costs: $670,210
Role: Co-Mentor
28. K01DA054262 (PI: Gajos)
04/01/2022–03/31/2027
NIH/NIDA
Momentary Geospatial, Psychological, and Behavioral Risk for Substance Use in Young Adults Under Criminal Justice Supervision
This project investigates substance use risk with geographically-explicit ecological momentary assessment data and risk terrain modeling to develop a just-in-time adaptive intervention to reduce substance use in young adults enrolled in drug treatment court.
Total costs: $841,563
Role: Co-Mentor
29. K01HL148907 (PI: Tackett)
08/21/2019-07/31/2024
NIH/NHLBI
This Tobacco Regulatory K01 will provide much needed evidence regarding the immediate and longitudinal respiratory/pulmonary effects of youth electronic cigarette use.
Total costs: $963,190
Role: Co-Mentor
30. K99DA054260 (PI: Brett)
07/01/2022-06/30/2024
NIH-NIDA
Development of a Mobile Health Intervention for Electronic Cigarette Use among Young Adults
This study seeks to develop and test a mobile health intervention for young adults who use electronic cigarettes or are dual users of cigarettes and e-cigarettes leveraging evidence-based smoking cessation materials and pharmacotherapy along with qualitative feedback.
Total costs (K99 period only): $345,556
Role: Co-mentor
31. K99/R00DA046564 (PI: Emily Hébert)
K99 phase - 03/01/2019–07/31/2020
NIH/NIDA R00 phase - 08/01/2020–11/30/2024
Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking Cessation
The aims are to apply supervised machine learning methods to quantify personalized risk of smoking lapse, and evaluate the feasibility and preliminary effectiveness of delivering a personalized, just-in-time adaptive intervention driven by machine learning prediction of smoking lapse risk in real time.
Total Costs: $179,883 (K99), $746,990 (R00)
Role: Primary mentor
32. F31AA030163 (PI: Tanya Smit)
05/01/2022-04/30/2025
NIH/NIAAA
Microaggressions and Hazardous Drinking among non-Latinx Black Individuals with Chronic Pain
This dissertation project (N=100) aims to elucidate the distinct role of micro aggressions in alcohol use motivation and drinking directly and indirectly through emotion dysregulation among non-Latinx Black adults using time sampling methodology (over the course of 21 days). Direct Costs: $110,112
Role: Co-Mentor
Select Publications:
Businelle, M. S., *Hébert, E. T., Shi, D., *Benson, L., Kezbers, K. M., *Tonkin, S., Piper, M. E., & Qian, T. (2024). Investigating Best Practices for Ecological Momentary Assessment: Nationwide Factorial Experiment. JMIR, 26, e50275.
Businelle, M. (co-first author), *Becerra, J. (co-first author), Witten, C., Chen, S., Kezbers, K., Beebe, L., & Kendzor, D. E. (2024). Smartphone-based smoking cessation intervention (OKquit) for Oklahoma Tobacco Helpline users: Protocol for a randomized controlled trial. JMIR Research Protocols, 13, e56827.
Businelle, M. S., *Benson, L., *Hébert, E. T., Neil, J., Kendzor, D. E., Frank-Pearce, S., Kezbers, K. M., Vidrine, D., & Gaur, A. (2024). Project Phoenix: Pilot randomized controlled trial of a smartphone-delivered intervention for people who are not ready to quit smoking. Drug and Alcohol Dependence, 260, 111351.
Businelle, M. S., Perski, O., *Hébert, E. T., & Kendzor, D. E. (2024). Mobile health interventions for substance use disorders. Annual Review of Clinical Psychology, 20, 49-76.
*Ulm, C., Chen, S., Fleshman, B., *Benson, L., Kendzor, D. E., Frank-Pearce, S., Neil, J. M., Vidrine, D., & Businelle, M. S. (2024). Smartphone-based survey and message compliance in adults initially unready to quit smoking: A secondary analysis of a randomized trial. JMIR Formative Research, 8, e56003.
Benson, L., Chen, M., De La Torre, I., Hébert, E. T., Alexander, A., Ra, C. K., Kendzor, D. E., & Businelle, M. S. (2024). Associations between morning affect and later-day smoking urges and behavior. Psychology of Addictive Behaviors, 38, 277-295.
Tonkin, S., Kezbers, K., Noble, B., Cropsey, K., Kendzor, D., Oliver, J., & Businelle, M. (2023). Comparison of the Bluetooth iCOquit, piCO, and Vitalograph for the assessment of breath carbon monoxide among adults initiating smoking cessation and standardized canisters. Drug and Alcohol Dependence, 250, 110902.
Thrul, J., Howe, C. L., Devkota, J., Alexander, A., Allen, A. M., Businelle, M. S., Hébert, E. T., Heffner, J. L., Kendzor, D. E., Ra, C. K., & Gordon, J. S. (2023). A scoping review and meta-analysis of the use of remote biochemical verification methods of smoking status in tobacco research. Nicotine & Tobacco Research, 25, 1413-1423.
Garey, L., Zvolensky, M. J., Gallagher, M. W., Vujanovic, A., Kendzor, D. E., Stephens, L., Cheney, M. K., Cole, A. B., Kezbers, K., Matoska, C. T., Robison, J., Montgomery, A., Zappi, C. V., & Businelle, M. S. (2022). A smartphone-based intervention for anxiety and depression in racially and ethnically diverse adults (EASE): Protocol for a randomized controlled trial. Journal of Medical Internet Research: Research Protocols, 11, e40713.
Walters, S. T., Mun, E-Y., Tan, Z., Luningham, J. M., Hébert, E. T., Oliver, J. A., & Businelle, M. S. (2022). Development and preliminary effectiveness of a smartphone-based just-in-time adaptive intervention for adults with alcohol misuse who are experiencing homelessness. Alcoholism: Clinical and Experimental Research, 46, 1732-1741.
Businelle, M. S., Garey, L., Gallagher, M. W., Hébert, E. T., Vujanovic, A., Alexander, A., Kezbers, K., Matoska, C., Robison, J., Montgomery, A., & Zvolensky, M. J. (2022). An integrated mHealth app for smoking cessation in Black smokers with anxiety: Protocol for a randomized controlled trial. JMIR Research Protocols, 11(5), e38905.
Kendzor, D. E., Businelle, M. S., Vidrine, D. J., Frank-Pearce, S. G., Shih, Y. C. T., Dallery, J., Alexander, A. C., Boozary, L. K., Waring, J. J.C., & Ehlke, S. J. (2022). Mobile contingency management for smoking cessation among socioeconomically disadvantaged adults: Protocol for a randomized trial. Contemporary Clinical Trials, 114, 106701.
Perski, O., Hébert, E., Naughton, F., Hekler, E., Brown, J., & Businelle, M. (2022). Technology-mediated just-in-time adaptive interventions (JITAIs) to reduce harmful substance use: A systematic review. Addiction, 117, 1220-1241.
Hébert, E. T., Ra, C. K., Alexander, A. C., Helt, A., Moisiuc, R., Kendzor, D. E., Vidrine, D. J., Funk-Lawler, R. K., & Businelle, M. S. (2020). A mobile just-in-time adaptive intervention for smoking cessation: pilot randomized controlled trial. Journal of Medical Internet Research, 22(3), e16907. PMCID: 7091024
More research publications
Businelle Lab
Follow on Twitter at @stop_smokin_now